Navigation Links
In the lab and clinic, VCU Massey develops a new therapy for blood cancers
Date:6/2/2011

Richmond, Va. (June 2, 2011) Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.

Reported in the journal Clinical Cancer Research, the study determined the maximum tolerated dose with acceptable side effects for this novel drug combination. The trial represented the first time a proteasome inhibitor such as Bortezomib was combined with a cell cycle inhibitor such as Alvocidib to treat patients with cancer.

Proteasome inhibitors work by blocking the action of proteasomes, which are large protein complexes that help destroy proteins that are no longer needed by the cell. Cell cycle inhibitors disrupt the sequence of events that allow cells to undergo cell division and duplication. They also have the ability to block gene transcription.

The trial included 16 patients who had either indolent (non-aggressive) non-Hodgkin's lymphoma, mantle cell lymphoma or multiple myeloma. After they received the treatments over a 21-day cycle, there were two complete responses, meaning that all detectable traces of the cancer were gone, and five partial responses.

"Therapeutic responses tend to be rare in Phase I trials, but 44 percent of our patient sample responded to the therapy. Interestingly, some patients who previously had no response to Bortezomib, or progressed after Bortezomib therapy, responded to the combination," says Beata Holkova, M.D., a hematologist-oncologist at VCU Massey and co-investigator on this clinical trial. "Because of the small patient sample size, we can't draw definitive conclusions about the effectiveness of the therapy, but we were quite encouraged by the results."

The patients received Bortezomib intravenously on days 1, 4, 8 and 11 an
'/>"/>

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Kreativ Dental Clinic, Offering Dental Implant and Dental Services Abroad, Launches 3D Virtual Tours Online
2. VCU Massey research finds new link between inflammation and cancer
3. Key leukemia defense mechanism discovered by VCU Massey Cancer Center
4. VCU Massey Cancer Center awarded $2.4 million grant from Virginia Tobacco Commission
5. Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center
6. VCU Massey first to combine targeted agents to kill multiple myeloma cells
7. VCU Massey Cancer Center finds new biomarker that predicts breast cancer relapse
8. Personal Best Develops Workplace Weight Loss Program
9. M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms
10. UD team develops new method for producing proteins critical to medical research
11. UMass Memorial health care develops fully integrated EMR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... David Kekich, anti-aging icon and CEO of ... that the acceptance of his revolutionary approach of ... algorithms and then screening thousands of compounds against ... , “It took longer than I thought and ... said Kekich. "Client acceptance is exploding, early clinical ...
(Date:7/31/2014)... Malaysia (PRWEB) July 31, 2014 ... mymobileuni.com, entered into strategic alliance with Dr. Lawrence ... and provide content to http://www.mymobileuni.com its ... Channel http://www.mymobileuni.net/mu3/health.php will include courses, e-books ... who want to learn, re-skill or up-skill themselves ...
(Date:7/31/2014)... 2014 (HealthDay News) -- The virus that causes cold sores ... the absence of symptoms, according to a new study. ... the cells of people infected with the virus. This explains ... and why others get them only occasionally. The authors said ... "We thought when the disease was dormant, it ...
(Date:7/31/2014)... MO (PRWEB) July 31, 2014 Saint ... with an Excellence Through Insight award for Overall Patient ... and Systems (CG-CAHPS) database in multiple categories by HealthStream, ... their commitment to excellence in patient care. To qualify ... been a patient satisfaction-tracking client of HealthStream in 2013, ...
(Date:7/31/2014)... OK (PRWEB) July 31, 2014 Shiitakes ... As in the recipe for Quick-Fix Spaghetti Sauce below, ... second-most consumed mushroom worldwide, valued for their deep flavor ... mushrooms. They absorb flavors of the foods they're cooked ... texture and offer high-protein, low-fat nutrition. Shiitakes are rich ...
Breaking Medicine News(10 mins):Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:MyMobileUniversity and Fortech International Form Strategic Alliance That Will Enhance the Global Health and Medical Channel on Its Website 2Health News:Cold Sore Virus Active Without Symptoms, Study Finds 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 3Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 2Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 3
... encouraging results for the long-term efficacy of a meningitis ... effective when given to infants older than 5 months.// ... the United Kingdom in 1999. While the short-term effectiveness ... a study looking at the data from the four ...
... risk of developing dementia later in life, a healthy diet ... conducted, researchers followed nearly 1,500 participants for more than 20 ... were twice as likely to develop dementia later in life. ... in middle age were six-times more likely to develop dementia ...
... suggests that older patients can avoid the risk of stroke by ... who ate fish; one to four// times a week had ... atrial fibrillation), than those who ate fish less than once a ... greater benefit – as their risk was lowered by 31%. However ...
... on active baby boomers. Arthritis followed by knee replacement surgery ... middle-aged Americans. Now a new technique offers hope for active ... feet, crouching and clicking, kneeling and directing. His glamour photography ... lifeblood," he says. "If they don't work, I don't work." ...
... it safe for people with heart disease to travel by ... on // issues involving air travel for heart patients -- ... on implantable automatic defibrillators and pacemakers, the need for preflight ... dangerous blood clot that can arise in the leg when ...
... heart attack patients fare better after having a procedure to ... results // from a recent study. The study, conducted in ... a group of about 870 men and about 160 women ... heart attack. While both sexes had about the same success ...
Cached Medicine News:
(Date:7/31/2014)... July 31, 2014 Touro University California,s College ... selected as the recipient of a $150,000 grant by ... the University to increase research and classroom space on ... technology for the study of health sciences, and will ... needs and interests of our students," said Shelley ...
(Date:7/31/2014)... , July 31, 2014 Hovione today ... has successfully passed a pre-approval inspection by the ... carried out by the FDA Consumer Safety Officer, Ms. ... on 21 st July and concluded on the 25 ... with the principles and guidelines of Good Manufacturing Practices (GMP) ...
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
Breaking Medicine Technology:Touro University California Garners Grant From Long Foundation 2Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2
... MVP Marketing + Design, Inc., a Minneapolis-based, branding, communications ... of eleven American Graphic Design Awards for selected client ... online and retail promotions created for three separate divisions ... (Skin and Wound Care, Office Supplies and Stationery Products), ...
... announces the approval of CollaGUARD surgical adhesion barrier for ... surgery. The product will be launched this year through ... to seek approval in a number of additional territories, ... and to initiate the studies required for registration in ...
Cached Medicine Technology:MVP Sweeps 2011 American Graphic Design Awards with Nine of 11 Wins for 3M Projects 2Innocoll Announces European Approval for CollaGUARD®, Surgical Adhesion Barrier 2Innocoll Announces European Approval for CollaGUARD®, Surgical Adhesion Barrier 3
Substrate Plasma for Factor IX Assay by STA© Analyzers. Freeze-dried human plasma from which factor IX has been removed by selective immuno-adsorption....
Colorimetric Assay of Plasminogen Activity by STA© Analyzers....
Enzyme Immunoassay of -Thromboglobulin Antigen by ELISA Method, 96 tests....
Calibration Plasmas for Assaysof Unfractionated Heparins (UFH) using the Anti-Xa Method on STA© Analyzers....
Medicine Products: